A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT05494866 · TERMINATED
Trial details
- NCT number
- NCT05494866
- Sponsor
- German Cancer Research Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-07
- Primary completion
- 2024-03-15
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.